Andrea
Ducas

Vice President, Health Policy

she/her

Close

Contact
Andrea Ducas

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.

Andrea Ducas is the vice president of Health Policy at American Progress, where she leads the organization’s efforts related to health care and public health. Ducas has spent her career at the intersection of advancing policy and systems change and has extensive expertise in health care coverage and affordability; payment and care delivery system reform; and what it takes to support culture change in health care and public health. Prior to joining American Progress, Ducas was a senior program officer at the Robert Wood Johnson Foundation, where she developed more than $150 million in strategic grants and investments to transform health and health care systems in the United States—including major advocacy initiatives; field-leading programs to anchor care delivery and payment changes in health equity; significant research into drivers of health; technical assistance and leadership support to state and federal policymakers; and widely used data platforms and frameworks to help communities and organizations set health priorities.

Earlier in her career, Ducas worked in development and communications for the Center for Family Representation, a nonprofit law and policy organization in New York City, and she served as a visiting scholar with the U.S. Department of Health and Human Services’ Office of Disease Prevention and Health Promotion. Ducas holds a Bachelor of Arts in international relations from Brown University and a Master of Public Health in health policy and management from Columbia University’s Mailman School of Public Health.

Latest

Compact View

Film Screening: ‘The Bitter Pill’ Past Event

Film Screening: ‘The Bitter Pill’

A documentary about the biggest civil litigation in U.S. history that took on pharmaceutical companies and their role in the opioid epidemic. The film will be followed by a discussion with the filmmakers.

CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices Article

CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices

These briefs emphasize the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity.

CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices Article

CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices

This brief, filed by the Center for American Progress and the NAACP in response to Boehringer Ingelheim Pharmaceuticals Inc. v. U.S. Department of Health and Human Services et al., emphasizes the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.